Details of CPPsite entry with Sequence CAYGRKKRRQRRR |
Primary information | |
---|---|
PEPTIDE SEQUENCE | CAYGRKKRRQRRR |
CPPsite ID | 2511, 2512, 2517, 2518, 2648, |
PEPTIDE NAME | PTX-TAT-LP, PTX-C-TAT-LP, TAT-LP-PTX, T7/TAT-LP-PTX, TAT |
CHIRALITY | L, L, L, L, L |
LINEAR/CYCLIC | Linear, Linear, Linear, Linear, Linear |
SOURCE | Synthetic, Synthetic, Protein derived, Protein derived, Protein derived |
CATEGORY | Cationic, Cationic, Cationic, Cationic, Cationic |
SUB CELLULAR LOCALIZATION | Cytoplasm, Cytoplasm, Cytoplasm and Nucleus, Cytoplasm and Nucleus, Nucleus |
N-TERMINAL MODIFICATION | Conjugated with PTX via cysteine, Conjugated with PTX via cysteine, Cysteine addition, Conjugated with T7, Cysteine addition |
C-TERMINAL MODIFICATION | Conjugation with liposome-GSH, Conjugation with liposome-GSH, Conjugation with rhodamine LP, Conjugation with rhodamine LP, NA |
CHEMICAL MODIFICATION | NA, NA, NA, NA, NA |
UPTAKE EFFICIENCY | Higher uptake efficiency, Higher uptake efficiency, Lower uptake efficiency, Higher uptake efficiency, NA |
PROPOSED UPTAKE MECHANISM | Endocytosis, Macropinocytosis and caveolae mediated endocytois, Clathrin dependent pathway, Clathrin dependent pathway, Endocytosis |
INVITRO/INVIVO | In vitro and in vivo, In vitro and in vivo, In vitro and in vivo, In vitro and in vivo, In vitro and in vivo |
CELL LINE | Murine B16F1 melanoma tumor cells, Murine B16F1 melanoma tumor cells, A549, A549, BCECs and C6s cells |
In VIVO MODEL | B16F1 tumor-bearing C57 mice, B16F1 tumor-bearing C57 mice, BALB/c male athymic nude mice, BALB/c male athymic nude mice, Mice |
CARGO | Nanoparticle (PTX with liposome), GSH, Nanoparticle (PTX with liposome), GSH, Nanoparticle (Liposome), Nanoparticle (Liposome), Nanoparticle (Liposomes) |
PMID | 25449709, 25449709, 25482610, 25482610, 22188312 |
PATENT | Unknown, Unknown, Unknown, Unknown, Unknown |
Tertiary Structure (Technique) | 2511 (PEPstrMOD), 2512 (PEPstrMOD), 2517 (PEPstrMOD), 2518 (PEPstrMOD), 2648 (PEPstrMOD), |